医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ニュース
添付文書
薬の臨床実感＆助言集

眼科医療

Azura Ophthalmics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Azura Ophthalmics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

バイオテクノロジーヘルスケア眼科医療臨床試験　 TimeLine: 32nd Annual Virtual Healthcare Conference Azura Ophthalmics to Present at the Piper Sandler

2020年11月24日

NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreement

NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreement

バイオテクノロジーヘルスケア眼科医療製薬　 TimeLine: New Exclusive Distribution Agreement NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with

2020年11月23日

Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia

Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia

その他ヘルスバイオテクノロジーヘルスケアメンタルヘルス外科眼科医療臨床試験製薬　 TimeLine: and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA and OTX-TIC in Asia Ocular Therapeutix

2020年10月30日

Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries

Santen and Aerie Conclude Exclusive License Agreement for Rhopressa® and Rocklatan® in Japan and Several Other Asian Countries

ヘルスケアヘルス一般眼科医療製薬遺伝学　 TimeLine: and Rocklatan in Japan and Several Other Asian Countries Santen and Aerie Conclude Exclusive License Agreement for Rhopressa

2020年10月28日

Azura Ophthalmics Raises US$20 Million for Registration Studies for Treatment of Leading Cause of Dry Eye Disease

Azura Ophthalmics Raises US$20 Million for Registration Studies for Treatment of Leading Cause of Dry Eye Disease

バイオテクノロジーヘルスケアヘルス一般病院眼科医療製薬　 TimeLine: Azura Ophthalmics Raises US$20 Million for Registration Studies for Treatment of Leading Cause of Dry Eye Disease

2020年10月22日

首尔半导体自然光LED“SunLike”进驻欧洲幼儿园，帮助孩子们学习并保护眼睛

首尔半导体自然光LED“SunLike”进驻欧洲幼儿园，帮助孩子们学习并保护眼睛

ヘルスケア眼科医療　 TimeLine: SunLike 帮助孩子们学习并保护眼睛进驻欧洲幼儿园首尔半导体自然光LED

2020年10月21日

ソウル半導体の自然光LED「SunLike」、子供たちの学習向上と視力保護を目的とし、欧州幼稚園の照明に採用

ソウル半導体の自然光LED「SunLike」、子供たちの学習向上と視力保護を目的とし、欧州幼稚園の照明に採用

ヘルスケア眼科医療　 TimeLine: SunLike ソウル半導体欧州幼稚園照明視力保護

2020年10月21日

Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected for European Kindergarten Lighting to Support Children’s Learning and Eye Health

Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected for European Kindergarten Lighting to Support Children’s Learning and Eye Health

ヘルスケア眼科医療　 TimeLine: Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Selected for European Kindergarten Lighting to Support Children’s Learning and Eye Health

2020年10月20日

Rajasthan Royals Implement RightEye’s Advanced Dynamic Vision Technology to Improve Players’ Performance

Rajasthan Royals Implement RightEye’s Advanced Dynamic Vision Technology to Improve Players’ Performance

ヘルスケア眼科医療　 TimeLine: Advanced Dynamic Vision Technology to Improve Players Performance Rajasthan Royals Implement RightEye

2020年10月14日

三井化学收购疏水性防反射涂料生产商COTECⓇ

三井化学收购疏水性防反射涂料生产商COTECⓇ

ヘルスケア医療用品眼科医療　 TimeLine: 三井化学收购疏水性防反射涂料生产商COTEC

2020年10月13日